Peter Glazer, M.D., Ph.D.

Dr. Peter Glazer is chair of the department of therapeutic radiology, professor of genetics, and the Robert E. Hunter professor of therapeutic radiology at the Yale School of Medicine. His research focuses on elucidating pathways of DNA repair in cancer and developing novel agents for cancer therapy and for gene therapy. In addition to Gennao … Read more

Elias Quijano, M. Phil.

Elias Quijano is an M.D. and Ph.D. student at the Yale School of Medicine, working with Dr. Glazer in the department of therapeutic radiology and genetics. He has over 10 years of experience in non-viral drug and gene delivery using polymer nanoparticles, drug eluting stents, biodegradable implants, and monoclonal antibodies. In addition to co-founding Gennao … Read more

Stephen Squinto, Ph.D.

Dr. Stephen Squinto is an entrepreneur and biotechnology industry veteran with more than 30 years of experience in drug development. He currently serves as chief investment officer and managing partner of J.P Morgan Life Sciences Private Capital. He previously was an executive partner at OrbiMed Advisors, and served as interim chief executive officer at Passage … Read more

Bruce Turner, M.D., Ph.D.

Dr. Bruce Turner is a medically trained radiation oncologist with deep experience transcending genetic research, drug development and healthcare portfolio management. Since 2017, Dr. Turner has served as Managing Director at Boxer Capital of Tavistock Group. He also spent five years at Hoffman-La Roche in various positions and helped lead the re-organization of the cardiovascular … Read more